REGN:NASDAQ
Regeneron Pharmaceuticals Inc
USD 738,72
arrow_upward
+1,69%(+12,25) 1D
USD 738,72
0,00% (0,00)
bedtimeAfter hours
Closed: 6 Okt., 16:00:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for REGN...
Open
USD 734,61
High
USD 740,51
Low
USD 727,16
Mkt. cap
76,97 mjd
Avg. vol.
721,38 k
Volume
615,06 k
Dividend
0,51%
Quarterly dividend
USD 0,94
Ex-dividend date
18 Aug. 2026
P/E ratio
18,26
52-wk high
USD 859,34
52-wk low
USD 541,00
EPS
USD 40,45
Beta
0,16
Shares outstanding
101,14 m
No. of employees
15 k
Open
USD 734,61
High
USD 740,51
Low
USD 727,16
Mkt. cap
76,97 mjd
Avg. vol.
721,38 k
Volume
615,06 k
Dividend
0,51%
Quarterly dividend
USD 0,94
Ex-dividend date
18 Aug. 2026
P/E ratio
18,26
52-wk high
USD 859,34
52-wk low
USD 541,00
EPS
USD 40,45
Beta
0,16
Shares outstanding
101,14 m
No. of employees
15 k
News stories
From web sources and news partners
Yahoo! Finance Canada
·
52 minute gelede
Expanded Sanofi Alliance And New Pipeline Data Could Be A Game Changer For Regeneron (REGN)
News Corp
·
2 uur gelede
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day
MarketWatch
·
2 uur gelede
Regeneron Pharmaceuticals Inc. stock outperforms competitors on strong trading day
AD HOC NEWS
·
4 uur gelede
Regeneron stock after-hours at EUR 650.25: plus 0.46 percent versus prior close
Profile
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap. Wikipedia
About Regeneron Pharmaceuticals Inc
CEOLeonard Schleifer
Employees15,3 k
Founded1988
HeadquartersTarrytown, New York, Verenigde State van Amerika
Sector-
Websiteregeneron.com